Stacy Hoffmann

Stacy Hoffmann is an accomplished professional in the pharmaceutical and biotech industry, currently serving as Executive Director of Commercial Effectiveness at Zevra Therapeutics since November 2023. Previously, Stacy held the position of Senior Director of Commercial Operations and Excellence at Fennec Pharmaceuticals Inc from May 2022 to September 2023. Prior experience includes roles such as Head of Field Training and Market Operations Effectiveness at Orphazyme, Sr. Director Training and Development, and Director of Training and Development at AveXis, Inc. From July 2012 to November 2018, Stacy worked at Lundbeck, progressing through positions including Director Commercial Operations and Associate Director of Marketing Operations. Earlier in the career, Stacy gained valuable experience as Sr. Manager of Marketing Operations Approval Process at Takeda Pharmaceuticals from 2000 to 2010. Stacy holds a Bachelor of Science degree from Elmhurst University.